Yüklüyor......
A Prospective Observational Registry of Repository Corticotropin Injection (Acthar® Gel) for the Treatment of Multiple Sclerosis Relapse
Background and Purpose: Effective relapse treatment is critical for minimizing disability in patients with multiple sclerosis (MS). Repository corticotropin injection (RCI; Acthar® Gel) has demonstrated efficacy for the treatment of MS exacerbations. However, there is limited real-world evidence ava...
Kaydedildi:
| Yayımlandı: | Front Neurol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7783159/ https://ncbi.nlm.nih.gov/pubmed/33414758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.598496 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|